Cancer Survival Rates Rose for Young Adults After Affordable Care Act

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 7, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, Oct. 7, 2024 -- During the first decade of the Affordable Care Act (ACA), survival and mortality increased among young adults with cancer who were eligible for dependent care expansion (DCE), according to a study published online Oct. 7 in Cancer.

Michael Roth, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues compared changes in cancer survival and mortality before and after enactment of the ACA DCE for young adults (ages: 12 to 18 years; 19 to 25 years [DCE-eligible]; and 26 to 32 years).

The researchers found that the DCE-eligible cohort was the only age group of the three evaluated that had improvements in both cancer survival and death rate trends after ACA implementation. The inflection year was 2010, the year the ACA was passed, for both survival and deaths. Six years from passage, the relative survival after cancer diagnosis was 2.6 and 3.9 times greater in the DCE-eligible age group than in the younger and older control groups, respectively. Furthermore, the cancer death rate in the DCE-eligible age group improved 2.1 and 1.5 times greater than in the younger and older control age groups, respectively.

"Within just 10 years after its passage, the DCE has allowed young adults with cancer who were covered by it to live longer and more likely be cured," lead author Archie Bleyer, M.D., of the Oregon Health & Science University in Portland, said in a statement. "Moreover, other serious physical or mental diseases are likely also having better outcomes since the ACA DCE and should be similarly evaluated, which could strengthen the need even more for ACA and Medicaid coverage and expansion."

Two authors disclosed ties to pharmaceutical companies.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-08 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords